Biote Corp (BTMD)
5.76
-0.30
(-4.95%)
USD |
NASDAQ |
May 07, 16:00
5.76
0.00 (0.00%)
After-Hours: 19:16
Biote Revenue (Quarterly): 45.70M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 45.70M |
| September 30, 2023 | 45.56M |
| June 30, 2023 | 49.26M |
| March 31, 2023 | 44.84M |
| December 31, 2022 | 44.48M |
| September 30, 2022 | 41.97M |
| Date | Value |
|---|---|
| June 30, 2022 | 41.36M |
| March 31, 2022 | 37.14M |
| December 31, 2021 | 37.54M |
| September 30, 2021 | 35.57M |
| June 30, 2021 | 34.75M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
34.75M
Minimum
Jun 2021
49.26M
Maximum
Jun 2023
41.65M
Average
41.97M
Median
Sep 2022
Revenue (Quarterly) Benchmarks
| Teladoc Health Inc | 646.13M |
| American Shared Hospital Services | 5.698M |
| Novo Integrated Sciences Inc | 3.171M |
| Astrana Health Inc | 353.04M |
| Cryo-Cell International Inc | 7.852M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 7.734M |
| Total Expenses (Quarterly) | 40.20M |
| EPS Diluted (Quarterly) | 0.18 |
| Enterprise Value | 236.19M |
| Gross Profit Margin (Quarterly) | 69.36% |
| Profit Margin (Quarterly) | 16.92% |
| Earnings Yield | -3.82% |
| Operating Earnings Yield | 19.25% |
| Normalized Earnings Yield | 19.00 |